Labor Market Pulse · Life Sciences · October 2026
Life Sciences Labor Market Report: Amarillo, TX MSA — October 2026
Amarillo life sci pay splits: biostats up, regulatory affairs down.
Amarillo's 3.5% unemployment rate sits among Texas's lowest even as private payrolls shed 700 jobs in September, while local Biostatistician pay ($139,166) now exceeds the national median and Regulatory Affairs pay ($95,473) trails it.
Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.
Key indicators
- Amarillo MSA unemployment rate: 3.5% — Ties for #2 lowest among TX metros, Sept 2026
- Private payroll change, Sept: -700 jobs — Offset by +900 government jobs same month
- TX biopharma job postings growth: +53% YoY — Jan-Aug 2026, outpacing hiring capacity
- National CRA quit rate: 1.9% — Signals constrained candidate mobility nationally
Key takeaways
Private payrolls contracted even as unemployment stayed low.
September's net 200-job gain masked a 700-job private-sector loss offset by government hiring, a signal that private employers — including life sci operations — are holding headcount flat instead of expanding. Treat local labor market tightness as a supply constraint.
Biostatistician pay outpaces the national rate here.
Metro median of $139,166 versus a national $131,958 suggests Amarillo-area employers are bidding up for a narrow pool of quantitative talent, a sign the local market is not benefiting from lower-cost-of-living arbitrage. This may signal the role has shifted from a commodity hire to a retention priority locally.
Regulatory Affairs pay softening locally tracks a national pullback.
Metro median fell to $95,473, down alongside the national decline to $103,780, even as national hiring data flags regulatory affairs among the hardest pharma roles to fill. A softening in advertised pay despite scarcity may reflect fewer active requisitions, with competition for incumbents still intact — worth confirming before resetting offer ranges.
CRA pay gap between Amarillo and national rates is widening.
Metro median of $63,664 sits nearly $26,000 below the national $90,065, a gap that national data attributes to experienced CRAs being the binding constraint on clinical trial capacity. Organizations relying on local CRA hiring may face longer time-to-fill than peers using regional or remote clinical operations models.
Median advertised pay by role — Amarillo, TX MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $82,765 | $123,070 | $131,979 | Significant increase | $130,339 |
| Clinical Research Associate | $53,226 | $63,664 | $70,536 | Moderate increase | $90,065 |
| Lab Technician * | $38,082 | $45,670 | $49,588 | Stable | $47,840 |
| Regulatory Affairs Specialist * | $70,793 | $95,473 | $116,373 | Moderate decline | $103,780 |
| Clinical Data Manager * | $96,453 | $122,953 | $135,700 | Stable | $123,653 |
| Biostatistician * | $98,485 | $139,166 | $160,691 | Moderate increase | $131,958 |
| Validation Engineer * | $82,756 | $104,143 | $112,977 | Moderate increase | $106,478 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Amarillo MSA unemployment held at 3.5% in September, among the lowest rates of any Texas metro and tight enough to constrain discretionary hiring even as nonfarm payrolls rose only 200 net jobs for the month, with government adding 900 and private employers shedding 700. Statewide, biopharma job postings surged 53% year-over-year through August while Texas added 4,500 life sciences jobs, a demand-supply gap that compounds Amarillo's already thin bench of credentialed scientific and regulatory talent.
What it means
Thin local supply of specialized scientific and clinical talent means Amarillo-based life sci employers compete directly against Texas Triangle markets (Houston, Dallas, Austin) where R&D and manufacturing talent density is higher, pushing build-vs-outsource decisions toward CRO and CDMO partnerships for roles like CRAs and biostatisticians that cannot be sourced locally at scale. Metro Research Scientist pay at $123,070 trailing the national median by roughly $7,000 suggests Amarillo employers hold a cost advantage worth defending through retention over new-hire premiums. Consider reviewing whether current build-vs-outsource splits in clinical operations and CMC reflect this metro's actual local talent density instead of statewide assumptions.
Looking ahead
Early indicator: Private-sector payroll contraction alongside flat unemployment is worth tracking into November; a second consecutive month of private losses would suggest employers are substituting overtime or outsourcing for net new hires.
Emerging pressure point: Texas biopharma job postings up 53% year-over-year statewide have not yet translated into comparable Amarillo-specific ad volume (job ads signal hiring demand; one ad often covers several openings) — watch whether Panhandle-area employers begin competing more aggressively for Lubbock- and Dallas-based specialists.
Worth watching: Regulatory Affairs advertised pay softened both locally and nationally this month despite persistent scarcity signals in national hiring surveys; a reversal in coming months would confirm demand is lagging behind cooling, not retreating alongside it.
Potential inflection point: National CRA quit rates remain pinned near 1.9%, meaning any Amarillo-based clinical operation expanding trial activity should expect extended fill times and may need to formalize CRO backup capacity before committing to in-house growth.
Sources
- Texas Workforce Commission — Amarillo MSA unemployment at 3.5% in September 2026
- Workforce Solutions Panhandle — Nonfarm employment +200 jobs with government +900, private -700
- Texas life sciences labor market research notes — Texas biopharma job postings up 53% YoY Jan-Aug 2026
- Biopharma industry hiring survey, 2026 — National CRA talent shortage concentrated in experienced-level roles
- Texas Workforce Commission / state life sciences data — Texas added 4,500 life sciences jobs in September
- National life sciences labor market research notes — National biopharma quit rate holding at 1.9%
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.